RETRACTION: W. Zhang, X. Wang, J. Li, et al., “Astragaloside IV Reduces OxLDL‐Induced BNP Overexpression by Regulating HDAC,” Journal of Healthcare Engineering 2021 (2021): 3433615, https://doi.org/10.1155/2021/3433615.
The above article, published online on 3 December 2021 in Wiley Online Library (https://wileyonlinelibrary.com), has been retracted by John Wiley & Sons Ltd.
This article has been retracted following an investigation undertaken by the publisher. This investigation has uncovered evidence of one or more of the following indicators of systematic manipulation of the publication process:1.Discrepancies in scope2.Discrepancies in the description of the research reported3.Discrepancies between the availability of data and the research described4.Inappropriate citations5.Incoherent, meaningless and/or irrelevant content included in the article6.Manipulated or compromised peer review
The presence of these indicators undermines our confidence in the integrity of the article’s content and we cannot, therefore, vouch for its reliability. Please note that this notice is intended solely to alert readers that the content of this article is unreliable. We have not investigated whether authors were aware of or involved in the systematic manipulation of the publication process.
The authors were informed of this retraction but did not provide a response.